Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884190 · ClinicalTrials.gov registry record · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
A NA study of Postpartum Hypertension, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 6,030
- Enrollment target
- 3
- Study locations
NCT05884190: Recruiting NA study of Postpartum Hypertension, sponsored by Yale University.
NCT05884190 is a NA study of Postpartum Hypertension that is actively recruiting participants, run by Yale University. The registered enrollment target is 6,030 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (330% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05884190, a NA study of Postpartum Hypertension, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 6,030 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.
Primary Outcome
Change in mean postpartum systolic blood pressure (SBP) at 6 weeks. A reduction in SBP indicates an improvement in postpartum hypertension.
Conditions Studied
Interventions
- OTHER Remote Medical Model (RMM)
- OTHER Community Health Model (CHM)
- OTHER SoC
Study Locations (3)
Connecticut
- Yale New Haven Hospital - New Haven
Massachusetts
- University of Massachusetts Memorial Health - Worcester
New York
- Oishei Children's Hospital University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,030 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT05884190 shows while recruiting
NCT05884190 is an interventional study that assigns participants to a tested intervention. Its 6,030 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (330% higher).
The record links to 1 condition, with Postpartum Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Remote Medical Model (RMM) is the first listed.
NCT05884190 reports a single indexed study location in Connecticut, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT05884190 about?
NCT05884190 is a clinical study titled "Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension". The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The...
What is the current status of trial NCT05884190?
This trial is currently recruiting. It is a NA study. The enrollment target is 6,030 participants. The study started on 2023-06-12. Estimated completion is 2027-10.
What conditions does trial NCT05884190 study?
This clinical trial studies the following conditions: Postpartum Hypertension.
What interventions are being tested in trial NCT05884190?
The interventions under investigation include: Remote Medical Model (RMM) (OTHER), Community Health Model (CHM) (OTHER), SoC (OTHER).
Who is sponsoring clinical trial NCT05884190?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05884190 being conducted?
This trial has 3 study locations across Connecticut, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05884190's enrollment target sits among peer trials
6,030 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI